미국 세포병리사 양성 교육제도와 전문성 향상을 위한 노력
The Education System for Cytologists and Efforts to Improve Professionalism in the United States of America
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
미국 세포병리사가 되는 길은 최소 학사학위와 Commission on Accreditation of Allied Health Education Programs 에서 인증 받은 세포병리사 양성 교육 과정 이수가 필요하다. 이를 기본으로 American Society for Clinical Pathology Board of Certification에서 주관하는 자격시험을 통과함으로써 세포병리사로 인정받는다. 현재 미국 세포병리사 양성 교육과정은 18개의 대학교와 병원에서 제공하며 그중 6개 대학교에서 석사 교육과정을 제공하는데 이는 병리의사의 부족과 의료체계의 발달에 따른 세포병리사 업무 영역 확장으로 기존의 프로그램을 석사학위 교육 수준으로 전환하는 추세다. 미국 세포병리사 전문성 향상을 위해 교육과정의 개선과 단일화, 자격 갱신제도, cytologist로의 명칭 전환 노력 등은 빠르게 변해가는의료 체계에 발맞출 뿐 아니라 세포병리사의 역량 강화로 보인다. 본 연구는 미국 세포병리사 양성교육제도와 전문성 강화 노력을 보고함으로써 대학 교수와 해외 취업을 준비하는 학생들에게 정보를 제공하고 우리나라 세포병리사의 전문성 향상을 위한연구에 도움을 줄 것이라 사료된다.
Abstract
The path to becoming a cytotechnologist (also known as a cytologist) in the United States of America (USA) requires a minimum of a bachelor’s degree and the completion of a training program certified by the Commission on Accreditation of Allied Health Education Programs. Aspirants are recognized as cytologists after passing a test administered by the American Society for Clinical Pathology Board of Certification on completion of a recognized cytotechnology training program. Cytotechnology training programs are currently provided by 18 universities and hospitals. Six of them provide master’s level education, unifying existing programs to the master’s level, which is necessitated due to a shortage of pathologists and the rapid development of the health care system. The improvement and unification of the curriculum, qualification renewal system, and the effort to change the title of qualified personnel from cytotechnologist to cytologist are seen as measures that would strengthen the capabilities of cytotechnologists as well as assist in keeping pace with the rapidly changing medical system. Knowledge about the educational courses available for cytotechnologists and the efforts to strengthen their expertise in the USA would be helpful to professors who guide students preparing for overseas employment and seeking professional improvement in Korea.
참고문헌 (22)
- Tan SY, "George Papanicolaou(1883-1962) : discoverer of the Pap smear", Singapore Med J, 56, pp.586~587 (2015)[DOI]
- "CLIA law ®ulations"[URL]
- "Regionally or nationally accredited colleges and universities"[URL]
- "Cytotechnology programs"[URL]
- "Find an accredited program"[URL]
- "State Licensure"[URL]
- "Cytologist and international cytologist, CT(ASCP)and CT(ASCPi) specialist and international specialist in cytology, SCT(ASCP) and SCT(ASCPi)"[URL]
- "Clinical Laboratory Improvement Act (CLIA)"[URL]
- Centers for Medicare & Medicaid Services(CMS), "Medicare, Medicaid, and Clinical Laboratory Improvement Amendments of 1988 (CLIA) program; cytology proficiency testing (PT)", Fed Regist, 74, pp.3264~3294 (2009)
- "Specialty/subspecialty information for approved accreditation organizations under CLIA"[URL]
- Chiou PZ, "Employer expectations for the MS-level cytology practitioner", Am J Clin Pathol, 153, pp.487~496 (2020)[DOI]
- "Cytopathology in focus: master’s for all-unifying training in cytotechnology"[URL]
- "Board of certification timeline (1920s to 2010s)"[URL]
- "US Credential maintenance program"[URL]
- Friedlander MA, "Perspectives on expanded scope of practice in cytotechnology", Lab Med, 49, pp.e52~e61 (2018)[DOI]
- "ASCP Board of Certification BOG adopts "cytologist" as new certification moniker" (2021)[URL]
- "Organizations cite scope expansion for cytotechs as reason to support name change opposed by CAP"[URL]
- 양병선, "임상병리사 교육과정 및 임상실습에 대한 연구", 대한임상검사과학회지, 50(3), pp.320~330 (2018), 대한임상검사과학회[DOI]
- 구본경, "한국, 일본, 미국 임상병리사 전문자격", 대한임상검사과학회지, 51(1), pp.1~14 (2019), 대한임상검사과학회[DOI]
- "Prerequisites for the examination"[URL]
- Soo Il Jee, "세포병리사의 업무량에 따른 적정인력 산정을 위한 업무실태 조사 연구", 대한임상검사과학회지, 53(2), pp.174~187 (2021), 대한임상검사과학회[DOI]
- "Master in diagnostic cytopathology program"[URL]